Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interleukin-33 signaling exacerbates experimental infectious colitis by enhancing gut permeability and inhibiting protective Th17 immunity.
Palmieri V, Ebel JF, Ngo Thi Phuong N, Klopfleisch R, Vu VP, Adamczyk A, Zöller J, Riedel C, Buer J, Krebs P, Hansen W, Pastille E, Westendorf AM. Palmieri V, et al. Among authors: vu vp. Mucosal Immunol. 2021 Jul;14(4):923-936. doi: 10.1038/s41385-021-00386-7. Epub 2021 Mar 2. Mucosal Immunol. 2021. PMID: 33654214 Free PMC article.
The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer.
Pastille E, Wasmer MH, Adamczyk A, Vu VP, Mager LF, Phuong NNT, Palmieri V, Simillion C, Hansen W, Kasper S, Schuler M, Muggli B, McCoy KD, Buer J, Zlobec I, Westendorf AM, Krebs P. Pastille E, et al. Among authors: vu vp. Mucosal Immunol. 2019 Jul;12(4):990-1003. doi: 10.1038/s41385-019-0176-y. Epub 2019 Jun 5. Mucosal Immunol. 2019. PMID: 31165767 Free PMC article.
GPR15 Facilitates Recruitment of Regulatory T Cells to Promote Colorectal Cancer.
Adamczyk A, Pastille E, Kehrmann J, Vu VP, Geffers R, Wasmer MH, Kasper S, Schuler M, Lange CM, Muggli B, Rau TT, Klein D, Hansen W, Krebs P, Buer J, Westendorf AM. Adamczyk A, et al. Among authors: vu vp. Cancer Res. 2021 Jun 1;81(11):2970-2982. doi: 10.1158/0008-5472.CAN-20-2133. Epub 2021 Mar 16. Cancer Res. 2021. PMID: 33727229 Free article.
C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice.
Banda NK, Tomlinson S, Scheinman RI, Ho N, Ramirez JR, Mehta G, Wang G, Vu VP, Simberg D, Kulik L, Holers VM. Banda NK, et al. Among authors: vu vp. Front Immunol. 2020 Oct 16;11:575154. doi: 10.3389/fimmu.2020.575154. eCollection 2020. Front Immunol. 2020. PMID: 33178202 Free PMC article.
Evaluation of Targeting Efficiency of Joints with Anticollagen II Antibodies.
Lofchy LA, Vu VP, Banda NK, Ramirez JR, Smith WJ, Gifford G, Gaikwad H, Scheinman RI, Simberg D. Lofchy LA, et al. Among authors: vu vp. Mol Pharm. 2019 Jun 3;16(6):2445-2451. doi: 10.1021/acs.molpharmaceut.9b00059. Epub 2019 May 15. Mol Pharm. 2019. PMID: 31091104 Free PMC article.
32 results